| Date Filed | Type | Description |
| 02/07/2014 |
SC 13G/A
| JENNISON ASSOCIATES LLC reports a 0% stake in Map Pharmaceuticals, Inc. |
| 02/07/2014 |
SC 13G/A
| PRUDENTIAL FINANCIAL INC has filed a Schedule 13D for MAP Pharmaceuticals, Inc. |
| 03/13/2013 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 03/13/2013 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 03/13/2013 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 03/11/2013 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)] |
| 03/11/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 03/11/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 03/11/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 03/11/2013 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 03/11/2013 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 03/11/2013 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 03/04/2013 |
SC 13D/A
| GAMCO INVESTORS, INC. ET AL reports a 0% stake in MAP Pharmaceuticals, Inc. |
| 03/01/2013 |
8-K
| Quarterly results |
| 03/01/2013 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 03/01/2013 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
| 03/01/2013 |
SC 13D/A
| MAP Pharmaceuticals, Inc. reports a 85.5% stake in MAP Pharmaceuticals, Inc. |
| 02/11/2013 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/11/2013 |
SC 13G/A
| MAP Pharmaceuticals, Inc. reports a 6.9% stake in Map Pharmaceuticals, Inc. |
| 02/11/2013 |
SC 13G/A
| MAP Pharmaceuticals, Inc. reports a 12.7% stake in MAP Pharmaceuticals, Inc. |
| 01/24/2013 |
5
| GIANAKAKOS ANASTASIOS (SVP, Chief Business Officer) has filed a Form 5 on MAP Pharmaceuticals, Inc. |
| 01/24/2013 |
5
| NELSON TIMOTHY S (President and CEO) has filed a Form 5 on MAP Pharmaceuticals, Inc. |
| 01/24/2013 |
5
| CHAI CHRISTOPHER Y (SVP & CFO) has filed a Form 5 on MAP Pharmaceuticals, Inc. |
| 01/24/2013 |
5
| KELLERMAN DONALD J (SVP,Clinical Dev & Med Affairs) has filed a Form 5 on MAP Pharmaceuticals, Inc. |
| 01/24/2013 |
5
| Borland Scott (SVP, Neurology Franchise) has filed a Form 5 on MAP Pharmaceuticals, Inc. |
| 01/23/2013 |
8-K
| Form 8-K - Current report |
| 01/23/2013 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer |
| 11/21/2012 |
8-K
| Other Events, Financial Statements and Exhibits |
| 11/06/2012 |
10-Q
| Quarterly Report for the period ended September 30, 2012 |
| 11/01/2012 |
8-K
| Quarterly results |
| 10/16/2012 |
8-K
| Other Events, Financial Statements and Exhibits |
| 08/29/2012 |
8-K
| Other Events, Financial Statements and Exhibits |
| 08/29/2012 |
PRN
| MAP Pharmaceuticals, Inc. Announces Full Exercise of Underwriter's Option to Purchase Additional Shares of Common Stock |
| 08/01/2012 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits |
|